BellBrook Labs logo — BellBrook Labs is dedicated to accelerating drug discovery a...

BellBrook Labs

BellBrook Labs is dedicated to accelerating drug discovery and biological research.

Founded 2002 United States Madison, United States 19 employees Seed Total: $187.29K Biotechnology, Health Care +1

General Information

Company Name BellBrook Labs
Founded Year 2002
Location United States Madison, United States
Employees 19
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with BellBrook Labs. To contact BellBrook Labs, visit bellbrooklabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About BellBrook Labs

BellBrook Labs is a biotechnology startup based in the United States, founded in 2007. The company is committed to speeding up drug discovery and biological research to enable the pharmaceutical industry to develop more effective therapies. Their proprietary Transcreener® HTS Platform is designed to expedite the movement of new targets into high-throughput screening (HTS) and simplify selectivity profiling within a target family. This technology, based on homogenous fluorescent immunodetection of nucleotides, has been rapidly validated and adopted by pharmaceutical and biotechnology screening labs globally. In June 2012, BellBrook Labs received a $187.29K investment in a Seed Round. The company's commitment to addressing critical technical challenges in drug discovery and their innovative technological solutions make them an attractive investment opportunity for venture capitalists looking to support advancements in the pharmaceutical industry.

Taxonomy: drug discovery, biological research, screening tools, pharmaceutical industry, Transcreener® Biochemical Assay Technology, high-throughput screening, enzyme families, cell signaling, therapeutic strategies, lead molecules, kinase assays, HTS assays, HCS, small R&D company, human health therapies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $187.29K -
15 Jun 2012

BellBrook Labs Alternatives & Competitors

BellBrook Labs vs

Boundless GPCR drug discovery

Seed
3 employees
Biotechnology, Health Care
BellBrook Labs vs
bit.bio
bit.bio United Kingdom

The Cell Coding Company

Series C
123 employees
Biotechnology, Health Care
BellBrook Labs vs

Achieve higher yields, improve quality & scalability with Viral Sensitizers (VSE™)

Grant
32 employees
Biotechnology, Health Care

FAQ About BellBrook Labs

BellBrook Labs is dedicated to accelerating drug discovery and biological research.
BellBrook Labs was founded in 2002.
BellBrook Labs is headquartered in Madison, United States.
BellBrook Labs operates in Biotechnology, Health Care and Health and Wellness. Its work centres on drug discovery, biological research, screening tools and pharmaceutical industry.
BellBrook Labs has approximately 19 employees.
BellBrook Labs has completed 1 funding round, raising a total of $187.29K. The latest funding stage is Seed.
Top alternatives and competitors to BellBrook Labs include Design Pharmaceuticals Inc., bit.bio, Virica Biotech, StemoniX, Resonant Sensors Incorporated. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BellBrook Labs and Design Pharmaceuticals Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for BellBrook Labs, https://bouncewatch.com/company/bellbrook-labs, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes